KRTX · Karuna Therapeutics
Acquired Company
Bristol Myers Squibb acquired Karuna Therapeutics for $330.00 per share in cash, for a total equity value of approximately $14.0 billion.
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative drugs for people living with psychiatric and neurological conditions. The company is headquartered in Boston, Massachusetts.
Market Cap
12.6B
52 Wk Range
$0.00 - $0.00
Previous Close
$329.83
Open
$329.83
Volume
N/A
Day Range
$329.83 - $329.83
Enterprise Value
N/A
Cash
185.8M
Avg Qtr Burn
-111.1M
Insider Ownership
4.99%
Institutional Own.
86.32%
Qtr Updated
Dec 31st 2023